Lilly And Queensland Government Invest In First-ever Australian Biotech VC Fund
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Eli Lilly and the Queensland government have formed a $250 million venture capital fund to invest in Australia's biotech sector, Queensland Premier Anna Bligh announced May 20
You may also be interested in...
Australia Ramps Up Early Research Via Medical Research Commercialization Fund
Funding for early-stage research has been a huge problem in Australia until recently, and new funding mechanisms have come just in time as research begun a decade ago moves into development.
CSL Invests $235 Million In Manufacturing Facility For Late-stage Development In Australia
PERTH, Australia - CSL Limited announced July 16 that it will invest $235 million to expand its manufacturing site in Broadmeadows, Australia to create Victoria's first large-scale biotechnology facility for late-stage development of new therapies for cancer, bleeding disorders, inflammation and infections
CSL Invests $235 Million In Manufacturing Facility For Late-stage Development In Australia
PERTH, Australia - CSL Limited announced July 16 that it will invest $235 million to expand its manufacturing site in Broadmeadows, Australia to create Victoria's first large-scale biotechnology facility for late-stage development of new therapies for cancer, bleeding disorders, inflammation and infections